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Abstract
Mp is an irradiation-induced mouse mutation associated with microphthalmia, micropinna and hind limb syndactyly. We
show that Mp is caused by a 660 kb balanced inversion on chromosome 18 producing reciprocal 3-prime gene fusion
events involving Fbn2 and Isoc1. The Isoc1-Fbn2 fusion gene (Isoc1Mp) mRNA has a frameshift and early stop codon resulting
in nonsense mediated decay. Homozygous deletions of Isoc1 do not support a significant developmental role for this gene.
The Fbn2-Isoc1 fusion gene (Fbn2Mp) predicted protein consists of the N-terminal Fibrillin-2 (amino acids 1–2646, exons 1–
62) lacking the C-terminal furin-cleavage site with a short out-of-frame extension encoded by the final exon of Isoc1. The Mp
limb phenotype is consistent with that reported in Fbn2 null embryos. However, severe eye malformations, a defining
feature of Mp, are not seen in Fbn2 null animals. Fibrillin-2Mp forms large fibrillar structures within the rough endoplasmic
reticulum (rER) associated with an unfolded protein response and quantitative mass spectrometry shows a generalised
defect in protein secretion in conditioned media from mutant cells. In the embryonic eye Fbn2 is expressed within the
peripheral ciliary margin (CM). Mp embryos show reduced canonical Wnt-signalling in the CM – known to be essential for
ciliary body development - and show subsequent aplasia of CM-derived structures. We propose that the Mp ‘‘worse-than-
null’’ eye phenotype plausibly results from a failure in normal trafficking of proteins that are co-expressed with Fbn2 within
the CM. The prediction of similar trans-acting protein effects will be an important challenge in the medical interpretation of
human mutations from whole exome sequencing.
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Introduction
The accurate prediction of the phenotypic consequences of
individual mutations is of increasing medical importance with the
rapid development of whole genome sequencing technologies.
Different mutations can have distinct effects on expression of the
gene, its function, or localisation of its product. It is therefore not
surprising that allelic heterogeneity can result in multiple distinct
disorders from mutations in a single gene (e.g. LMNA [1], FLNA
[2], FGFR1 [3]). Such heterogeneity, in combination with
stochastic effects and genetic and/or environmental modifiers,
also accounts for phenotypic variability within an individual
disorder.
Particular mutations cause disease due to a failure of normal
post-translational processing and protein folding. For example, the
mutation-specific induction of endoplasmic reticulum (ER) stress
responses seen in disorders including late onset neurodegenerative
diseases [4], congenital hearing loss [5] and skeletal dysplasias [6].
The mechanisms proposed for pathogeneisis associated with ER
stress include: loss of function of the mutant protein [7], alteration
of the cell specific differentiation state [6] or uncharacterised
generalised cytopathy [4].
Anophthalmia (absence of the eye) and microphthalmia (small
eye) are important causes of congenital visual impairments in
developed countries with a live birth prevalence rate of 0.2 and 1.7
per 10,000 live births respectively [8,9]. In most cases the cause of
anophthalmia/microphthalmia remains unknown [10] although
several single gene causes have been discovered including SOX2
[11,12], OTX2 [13], STRA6 [14], FOXE3 [15], SMOC1 [16,17,18]
and PAX6 [19]. Of these, heterozygous loss-of-function mutations
in SOX2 are the most common, accounting for 20–40% of
bilaterally affected cases [20]. SOX2 functions at multiple stages
during eye development, including during lens induction [21,22]
and formation and maintenance of the ciliary margin (CM) at the
distal peripheral rim of the optic cup [23]. The CM forms the
ciliary epithelium and the inner layer of the iris and controls ciliary
muscle and stroma development [24]. At the boundary of the CM
and the neural retina (NR), multipotent cells make a binary
decision to commit to either CM or NR fate [23]. SOX2
expression, which marks the boundary between CM and NR, is
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dependent on canonical Wnt-signaling [25,26]. Loss of either
Wnt-signalling or SOX2 expression in the CM leads to failure of
the development of the ciliary body structures and thinning and
rosetting of the neural retina [23,27,28].
The Mp mouse was generated through the irradiation muta-
genesis programme at the Oak Ridge National Laboratory in the
1960’s. Mp homozygotes appeared to be anophthalmic and to
have syndactylyyly of the hindlimbs [29]. Here, we identify the
cause of Mp as a balanced 660 kb inversion on chromosome 18.
The consequent gene fusion events result in the production of a C-
terminally truncated fibrillin-2 protein that is retained in the
rough-ER(rER) of expressing cells. Null mutations of Fbn2
accurately phenocopy the Mp limb anomalies but are not
associated with any ocular malformation [30,31,32]. Fbn2Mp
inclusions trigger the unfolded protein response (UPR) in a subset
of cells within the CM resulting in aplasia of the ciliary apparatus
with thinning and rosetting of the neural retina. The UPR seen in
Mp is associated with signalling and patterning anomalies and a
reduction in general protein secretion in Fbn2Mp expressing cells.
This mechanism has broader significance in the interpretation of
human disease-causing mutations. It suggests that the phenotypic
effect of specific UPR-inducing mutations may not result from loss
of that gene product but rather from loss of co-expressed gene
products that are also processed through the ER.
Results
Main adult phenotypes of Mp
We bred Mp onto both the C57BL/6J inbred, and the CD1
outbred background strains. The phenotype in these mice was
consistent with that documented in the previous report ([29];
Figure 1A–H), with small eyes and ears in adult heterozygotes
(Figure 1B; Mp/+) and small ears, apparent anophthalmia and
hindlimb syndactyly in homozygotes (Mp/Mp; Figure 1C). The
eyelids in Mp/Mp animals never opened, however contrary to the
original report, microphthalmia rather than anophthalmia was
identified on dissection (Figure 1D). Further analyses revealed that
the Mp/Mp limb phenotype ranged in severity from osseous
fusions of the entire phalanges of digits 2–3–4 (Figure 1H), to
simple soft tissue syndactyly affecting these digits (not shown).
Digits 1 and 5 were never affected and no metatarsal abnormalities
were identified. Consistent with the original report in which
homozygotes were described as runted, we observed significant
weight differences between mutant and Wt animals (Figure S1).
Mp mutant phenotypes were fully penetrant throughout crosses of
all genetic backgrounds tested (Figure S1).
Ciliary body malformation and aberrant developmental
Wnt signalling in the Mp eye
Histological analysis at adult stages (P21) revealed pan-ocular
structural defects in Mp (Figure 2A–C). In particular, the neural
retina cell layers displayed severe rosetting and the vitreous was
absent from the anterior chamber and posterior eye. Immunoflu-
orescence studies revealed the nature of the retinal disruption with
rosettes composed primarily of disorganised rod photoreceptors,
and reduced numbers of cells at the inner nuclear layer (Figure
S2). Furthermore, ectopic ganglion cells were identified in multiple
regions of the Mp/Mp retina and expression of GFAP was
observed, indicative of gross damage to the retina. In both Mp/M
and Mp/+, the ciliary body was consistently absent however the
iris appeared to form normally (Figure 2D). Although retinal
lamination is not fully complete until approximately three weeks
after birth, the ciliary body develops during mid gestation from
non-pigmented ciliary epithelial cells. The anterior region of the
early developing retina, and future ciliary epithelium, is marked
specifically by canonical Wnt signalling and we therefore crossed
Mp to BAT-gal [33], a Wnt-reporter strain that expresses beta-
galactosidase in the presence of activated beta-catenin. In Mp/Mp-
BAT-gal+/2 E14.5 mice, we detected significantly reduced
canonical Wnt signalling in the anterior retina as shown by the
loss of positively stained cells (Figure 2E–F, and Figure S2).
Furthermore, at E15.5 a marked reduction in the size of the
developing non-pigmented ciliary was observed upon histological
staining as well as staining for the anterior retina marker Pax6
(Figure 2G–J). Furthermore, we revealed reduced total retinal size
in Mp/Mp eyes at the same developmental stage (Figure S2). We
therefore concluded that the Mp eye phenotype resulted from
perturbations to normal ocular development, and first identifiable
at the region of the developing ciliary epithelium.
Genetic mapping of Mp to the Fbn2 locus
We performed a whole-genome scan using microsatellite
markers on heterozygous Mp mice backcrossed to C57BL/6J,
and identified enrichment for background strain C3H-specific
alleles co-segregating with Mp at three consecutive markers on
chromosome 18 (data not shown). During fine mapping, no
recombination events between markers D18Mit74 and D18Mit184
were found in 43 Mp/+ animals tested (Figure 3A). The Mp
mutation was thus likely to be located between approximately
53 Mb and 67 Mb on chromosome 18. Fbn2 (RefSeq Gene
NM_010181), an extracellular matrix protein, maps within this
interval. The hind-limb phenotype of Mp was consistent with
previously published loss of function Fbn2mutations [30,31,32,34].
Human mutations in FBN2 are associated with crumpled ear
helices in affected patients [35,36,37] and comparable ear
phenotypes were observed in Mp. However, heterozygous FBN2
mutations in humans do not cause ocular malformations and no
ocular phenotype has been reported for Fibrillin-2 null mice
[30,31,32,34]. Furthermore, our histological examination of adult
and neonatal Fbn2-null eyes revealed no ocular phenotype on
genetic backgrounds analogous to Mp (Figure S3).
Nevertheless, we considered Fbn2 to be a good candidate for
Mp. Standard RT-PCR was unable to amplify a 39- region of the
Fbn2 cDNA (Figure 3B). Using 39-RACE we identified a fragment
present in Mp/Mp but absent from Wt mRNA, and a
corresponding absence of the Wt Fbn2 amplicon in Mp/Mp
(Figure S3). Cloning and sequence analysis of the Mp-specific Fbn2
amplicon identified that Fbn2Mp was transcribed up to and
Author Summary
With the current increase in large-scale sequencing efforts,
correct interpretation of mutation consequences has never
been more important. Here, we present evidence for a
trans-acting protein effect in a novel mutation of Fbn2,
associated with severe developmental eye defects not
found in loss of function Fibrillin-2 alleles. The mutant
protein is expressed in the developing eye but is unable to
exit the cells, instead forming large protein aggregates
within the endoplasmic reticulum. We observed ER-stress
in mutant eyes, and detected a general reduction to
secretion of co-expressed proteins in cell cultures. We
propose that similar effects could be caused by mutations
to other proteins that are trafficked through the ER,
highlighting a disease mechanism that results in different
clinical outcomes than observed, or predicted, from loss-
off-function alleles.
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including all of exon 62, following which the mRNA contained the
full sequence of the terminal exon from Isoc-1 (RefSeq ID
NM_025478) (Figure 3C), a 5-exon gene of undetermined function
located ,1 Mb from Fbn2 on chromosome 18. Using combina-
tions of Fbn2 and Isoc1 specific primers we discovered that this
fusion was reciprocal and balanced so that the terminal Fbn2 exons
(exons 63–65) replaced the final exon (exon 5) of the Isoc1
transcript (Figure S3), creating a 7-exon mRNA. Sequencing
genomic DNA confirmed this to be a balanced inversion of
chromosome 18 [NCBI37/mm9: Chr18:58,178,418–58,835,146]
(Figure 3D). The predicted consequence for the translated
Fibrillin-2Mp protein was replacement of the C-terminal 261
amino acids (aa) from position 2646, with an 11 aa out-of-frame
extension followed by a termination codon, encoded by the out-of-
frame final exon of Isoc1 (Figure 3E). Fibrillin-2Mp lacks the
evolutionarily conserved predicted furin cleavage site present in
the full-length protein (Fbn2 2769–73 aa; RRKR) [38].
In contrast, the inversion predicted nonsense-mediated decay of
the Isoc1Mp transcript due to the frameshift-induced stop codon in
the 5th of the 7 exons of this fusion gene [39,40]. Consistent with
this we observed approximately 50% reduction in Isoc1Mp mRNA
levels by quantitative RT-PCR from developing eye tissue (Figure
S3). The Slc27a6 gene, encoding a member of the fatty-acid
transport family protein, is located between Fbn2 and Isoc1 and its
orientation was changed by virtue of its position at the centre of
the Mp genomic rearrangement, possibly affecting its cis-regula-
tion. However the gene itself was not structurally altered and we
observed no change in the low level of Slc27a6 expression that
could be detected in Wt and Mp samples by RT-PCR (Figure S3).
Additionally, signal was not detectable for Slc27a6 or Isoc1 at any
stage when analysed by whole mount in situ hybridisation (WISH)
in Wt and mutant samples (Figure S4). Although WISH is not
sensitive enough provide conclusive proof, this data suggests that
the developmental expression of these genes was not significantly
changed or ectopically upregulated in Mp embryos. However, we
could exclude loss of low-level expression of either of these genes as
a cause of the ocular phenotype based on previous genetic studies.
A chromosomal deletion causes the shaker-with-syndactylism (sy)
phenotype extends at least between the microsatellite markers
D18Mit124 at 57.61 Mb (NCBI37/mm9 C57BL/6J) and
D18Mit205 at 58.95 Mb, encompassing Isoc1 (58.82–58.84 Mb)
and Slc27a6 (58.72–58.77 Mb) as well as Slc12a2 and Fbn2 [34].
Mice heterozygous for sy have no morphological phenotype, and
homozygotes have fused digits due to loss of Fbn2 and are deaf
because they lack Slc12a2 [41]. The truncation of Fibrillin-2Mp
thus remained the sole candidate and we therefore focussed our
investigations on the Fbn2Mp gene product.
Fibrillin-2 distribution was disturbed in Mp
We performed whole-mount and tissue section in situ hybrid-
isation to determine the embryonic expression patterns of Fbn2 Wt
and Mp mouse embryos. Fbn2 showed site and stage specific
expression in the developing eye, limb and tail in early embryos
and gene expression patterns did not differ between Wt and Mp in
any tissue or at stage analysed (Figure 4A & B; and Figure S4).
Expression of Fbn2 has recently been well documented in the
developing mouse eye, with strong expression observed in the
developing non-pigmented ciliary epithelium at the anterior
retina, with expression also observed in cells of the cornea and
the periocular mesenchyme [42]. Similarly, we observed Fbn2
expression in our analysis of Wt and Mp/Mp eyes at E13.5, with
no differences observed between genotypes (Figure 4C–D).
Consistent with these sites of expression, using the Fibrillin-2
specific polyclonal pAb868 antibody, we observed Wt Fibrillin-2
protein in extracellular regions of the periocular mesenchyme and
in the anterior region of the eye between the neural retina and lens
(Figure 4E). In contrast, Fibrillin-2Mp was absent from these
extracellular areas and instead was observed within cells of the
anterior eye (Figure 4F), with the strongest signal detected in the
non-pigmented ciliary region. Fibrillin-2Mp was also observed in
the retinal pigmented epithelium (RPE) and in the corneal
mesenchyme (consistent with Fbn2 mRNA distribution). We then
looked at Fibrillin-2 distribution in other tissues known to express
Fbn2 and revealed similarly marked differences in protein
localisation between Wt and Mp (Figure S4). In all samples
analysed (mouse embryonic fibroblasts (MEFs); femoral articular
Figure 1. The Mp phenotype was characterised by severe ocular and limb abnormalities. (A–C) Heterozygous (Mp/+) animals had
apparent microphthalmia (arrow) and reduced ear size (arrowhead) compared to Wt. Homozygotes (Mp/Mp) were more severely affected with closed
eyes, indicating anophthalmia (arrow), and further reduced ear size (arrowhead). (D) Dissection of adult eyes revealed microphthalmia in both Mp
genotypes and revealed a graded reduction in size compared to Wt (scale bar = 3.0 mm). (E–G) Hindlimb syndactylyyly was identified in Mp/Mp
animals with the presence of only 4 digits on each paw compared to Wt and Mp/+. (H) Skeletal analysis revealed the presence of all 5 complete digital
rays in Wt and Mp/+ hindlimbs but revealed osseous fusions of phalanges (arrow) within Mp/Mp mid-axial digits (digits 2–4).
doi:10.1371/journal.pgen.1003998.g001
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cartilage and skin), Wt Fibrillin-2 protein was detectable in typical
extracellular microfibril structures, but mutant protein was
confined to intracellular foci adjacent to cell nuclei and was not
observed in extracellular regions.
Fibrillin-2Mp formed stable fibrils within the endoplasmic
reticulum
To further identify the consequence of the Mp truncation to
Fibrillin-2 distribution, and to explore possible consequences to
expressing cells, we performed transmission electron microscopy
(TEM) of eye scleral cells on mutant samples. These revealed
inclusions located within the enlarged rough endoplasmic reticu-
lum (rER) lumen that were organised into thick fibril-like
aggregates, with apparent structural periodicity (Figure 5A–B).
The inclusions were confirmed as Fibrillin-2 positive by immuno-
EM (Figure 5C) and by immunofluorescence (Figure 5D). Deposits
of Fibrillin-1-containing fibrils with similar ultrastructural appear-
ance to the Fibrillin-2Mp inclusions have been previously identified
in extracellular normal human cartilage matrix [43], however the
inclusions in our study did not contain Fibrillin-1 when tested by
immunofluorescence (Figure S4), or by immuno-EM (not shown),
and were exclusively intracellular. Nevertheless, both these results
suggest that under some physiological conditions, Fibrillins can
produce atypically banded fibrils. Immunofluorescence confirmed
that the Fibrillin-2Mp inclusions were ER-specific, and did not
localise within the golgi (figure 5E–G).
Figure 2. Mp eyes displayed structural defects and abnormal ciliary development. Histological comparison of eye tissues in Wt (A), Mp/
+(B), and Mp/Mp (C) at P21 revealed severe pan-ocular defects. Mutant eyes displayed microphthalmia and retinal rosetting (arrowheads), together
with loss of vitreous in the anterior chamber and between lens and retina. Lens size was also reduced in both mutant genotypes. Scale bars = 500 mm;
sections are oriented in the sagittal plane. (D) Enlarged view of iris and the anterior region of retinas revealed the absence of ciliary body structures in
both mutant types. (E–F) Genetic crosses of Mp with the Wnt-signalling reporter mouse line BAT-gal, revealed a significant reduction in galactosidase-
positive cells in E14.5 Mp retinas compared to Wt, specifically in the dorsal and temporal regions of the anterior retina (n= 8 per genotype). In
contrast, non-ocular tissue displayed slightly increased staining in Mp:B-gal compared to Wt:B-gal, due to the slight increase in staining time in these
samples. Ventral regions had low expression in both genotypes and were used as reference for quantitative comparison (Figure S2). (G–H)
Histological analysis of anterior retinas at E15.5 revealed a reduction in non-pigmented ciliary body tissue (arrows) in Mp/Mp compared to Wt. (I–J)
Immunohistochemical staining of anterior retinal structures with antibodies specific for Pax6 and Sox2 at E15.5 revealed reduction in the Pax6-
positive and Sox2-negative non-pigmented ciliary epithelial region in Mp. Scale bars, 50 mm. The asterisk in C indicates artefactual disruption to the
corneal epithelium during sample processing. Abbreviations: ac, anterior chamber; c, cornea; cb, ciliary body; ir, iris; ln, lens; nr, neural retina; rpe,
retinal pigmented epithelium; vb, vitreous body.
doi:10.1371/journal.pgen.1003998.g002
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Fibrillin-2Mp inclusions triggered ER-stress
We hypothesised that the presence of large inclusions could
disrupt normal ER mechanisms and secretory function. First, we
analysed expression of Xbp1, a widely used marker ER-stress or the
unfolded protein response (UPR)[44]. Specifically, a quantitative
assay was devised to measure the ratios of unspliced versus UPR-
specific Xbp1 transcripts. Validation was performed with cells
cultured with increasing concentrations of tunicamycin (not
shown). We then assayed Mp/Mp and Wt RNA samples from
MEFs and from dissected E13.5 and E16.5 embryonic eye tissues,
and found that relative levels of Xbp1s were significantly increased
in all Mp/Mp samples compared to Wt (Figure 5H). We next
analysed embryonic ocular expression of the UPR chaperone
protein Hspa5, and observed expression in Mp, but not in Wt,
specifically in the ciliary epithelium (Figure 5I–J). Immunostaining
for Protein Disulphide Isomerase (PDI), revealed that Mp embryos
had enhanced staining in the non-pigmented ciliary epithelium
and adjoining RPE, co-localising with the Fibrillin-2Mp inclusion-
positive cells, whereas equivalent Wt cells were negative for PDI
expression (Figure S5). In combination, these data confirmed ER-
stress in developing Mp eyes, in regions consistent with the
distribution of Fibrillin-2Mp inclusions at the anterior developing
ciliary margin.
We then investigated whether the presence of Fibrillin-2Mp
inclusions resulted in an increase in apoptosis in the developingMp
eye. We reasoned this could provide a straightforward explanation
for the loss of retinal and ciliary epithelial cells observed in Mp.
Immunostaining for activated Caspase-3 revealed increased
numbers of apoptotic cells in the embryonic mutant retinas
compared to Wt (Figure 5K). The positive cells were evenly
dispersed throughout the entire neural retina, but surprisingly
these were not enriched in the areas with the highest number of
Fibrillin-2Mp-positive cells, i.e. the non-pigmented ciliary epithe-
lium and adjacent RPE (Figure S5). This suggested that additional
or alternative pathological mechanisms account for the disruptions
to the developing anterior eye in Mp.
Figure 3. Mp mapped to a balanced 660 kb inversion on chromosome 18 disrupting Fbn2 and Isoc1. (A) Haplotype analysis using DNA
samples from 3rd backcross (from parental strain C3H onto C57BL/6J) Mp/+ animals (n = 43) for four microsatellite markers on chromosome 18
revealed there had been no meiotic recombination events between markers D18MIT74 and D18MIT184, defining an Mp candidate loci between 53–
67 Mb (NCBI37/mm9 mouse assembly). (B) Semi-quantitative RT-PCR analysis of the Fbn2 mRNA for each genotype revealed a failure to amplify the
39-terminal region (bottom panel) of the transcript in Mp/Mp and an apparent reduction in Mp/+, compared to the normal amplification of a more
central region of the Fbn2 mRNA (top panel). (C) Sequence chromatogram from 39-RACE revealed cDNA sequence from Fbn2 exon 62 fused with
sequence from Isoc1, a 5-exon gene positioned ,1 Mb in cis from Fbn2 on chromosome 18. Fbn2 has 65 exons, Isoc1 has 5 exons. The Mp transcript
was composed of Fbn2 exons 1–62 spliced directly to exon 5 of Isoc1 with 100% homology and no extra nucleotides added or removed. (D) The Mp
genomic rearrangement comprised a balanced inversion of chromosome 18 with breakpoints positioned in the 39-introns of Fbn2 (intron 62) and
Isoc1 (intron 4). Breakpoints were located at Chr18:58,178,418 and Chr18:58,835,246. Note that Fbn2 is transcribed from the minus strand. (E) Fibrillin-
2 Wt (top) and Fibrillin-2Mp (bottom) proteins with domains indicated. Fibrillin-2Mp is predicted to be missing the final calcium-binding EGF domain
and its unique C-terminus, which have both been replaced by a sequence of 11 exogenous amino acids (red text), encoded out of frame from the
Isoc1 terminal exon and followed by stop codon. Note also the removal of the endogenous RKKR furin cleavage domain.
doi:10.1371/journal.pgen.1003998.g003
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Protein secretion defects in UPR-affected cells
We then considered whether the presence of Fibrillin-2Mp
inclusions and the consequential induction of UPR prevented the
secretion of other extra-cellular proteins expressed in the same
cells. We took multiple independent primary Wt and Mp MEF
cultures and analysed their conditioned media using quantitative
label-free mass-spectrometry. We found reduction in the secretion
of many proteins, of which the most severely affected were
collagens (Col6a1; Col3a1; Col1a2; Col1a1; and Col12a1),
Periostin and Follistatin-like 1 (Figure 6A). Confirmation of the
MS data was performed by immunoblotting for one of the
identified enriched proteins, Col6a1, which revealed elevated
intracellular protein levels in Mp (Figure 6B). Albumin supple-
mented into the culture media was detected at equivalent levels by
these analyses, and Coomassie-stained SDS-PAGE gels of total
secreted proteins were used as a further experimental control. To
ensure that transcriptional down-regulation was not responsible
for the differences seen in protein levels, we assessed the relative
mRNA levels of the affected proteins and found the expression of
all the genes to be equivalent to Wt (Figure 6C). As a
complementary assay, we transfected Wt human RPE1 cells with
a plasmid encoding a tagged secreted protein (Wnt3A-FLAG) and
added tunicamycin (Tn) to the cell culture medium to induce the
UPR. Increased levels of Hspa5 in cell lysates confirmed that the
Tn-treated cells were undergoing the UPR, and we saw a
coincident reduction to secreted Wnt-FLAG in these cells
compared to similarly transfected cells without Tn (Figure S6).
We also observed a reduction in the mass of the migrating Wnt-
FLAG protein, consistent with reduced glycosylation in the Tn-
treated cells. Thus, Fibrillin-2Mp inclusions have a negative effect
on protein secretion, and this is a likely consequence of ER-stress.
Discussion
In humans, mutations in the FIBRILLIN gene family result in
fibrillinopathies, diseases that display a broad phenotypic spectrum
consistent with their developmental expression patterns [45,46].
Autosomal dominant (AD), and less commonly autosomal
recessive, mutations in FBN1 result in the skeletal, cardiovascular
and ocular features of Marfan syndrome (MIM #154700),
whereas AD FBN2 mutations typically affect skeletal regions in
arthrogryposis, in which patients usually present with long digits,
distal joint contractures and crumpled ears, but rarely with ocular
or cardiovascular complications. Haploinsufficiency for FBN1
appears to be the mechanism responsible for the majority of cases
of Marfan syndrome [47]. However, dominant-negative effects
appear to be responsible for the very severe phenotypes associated
with neonatal and infantile Marfan syndrome. In these cases the
causative mutations cluster within exons 24–32 [48]. The cognate
region of FBN2 is the most commonly mutated in Beal syndrome
and would plausibly be associated with a similar dominant
negative effect [49]. An interesting phenotype of neonatal
progeroid features, Marfan syndrome and generalised lipodytro-
phy (Wiedemann-Rautenstrauch syndrome) has recently been
described in association with FBN1 mutations located in the C-
terminal domain of the protein [50,51,52]. The pathogenic
mechanism is not yet clear but it will be important to determine
if the mutant protein is normally secreted.
Mp displayed phenotypic overlap with the human fibrillinopa-
thies, including contractures, small ears and skeletal malformations
in the limbs. Studies in mice have shown that the Fibrillins are
differentially expressed through embryonic development, with
Fbn2 transcripts appearing first and coinciding with early
morphogenesis and elastic fibre assembly. The overlapping, but
delayed expression of Fbn1 is consistent with a more structural role
after defined organ structures have been established. Although
both Fibrillin-1 and Fibrillin-2 are present during embryogenesis,
neither is absolutely necessary, as microfibrils and elastic fibres are
formed in the absence of either protein. To date, five separate loss
of function mouse mutations in Fbn2 have been described, all with
Figure 4. Fibrillin-2Mp aggregated into large intracellular
inclusions within the rough endoplasmic reticulum. (A–B) Whole
Mount In Situ Hybridisation to Fbn2 using antisense 39-UTR riboprobes
of Fbn2 for Wt and Isoc1 for Mp/Mp in early Wt and Mp/Mp embryos
(E11.5) revealed the spaciotemporal expression of the variant Fbn2
alleles appeared unaffected by the genomic inversion and that cis-
regulation of the genes was unchanged. Fbn2 was expressed in the
developing eyes (arrows), limbs (arrowheads), and tail (asterisks), and
expression was also observed in the somites. (C–D) Section In Situ
Hybridisation for Fbn2 at E13.5 again showed that mutant Fbn2
expression was comparable to Wt in the eyes, with Fbn2 identified in
the periocular (m) and corneal (c) mesenchyme, and faintly in the
anterior retina (arrows). No expression was identified in the lens (ln).
Scale bars in, 100 mm. (E–F) Immunohistochemical analysis of the
anterior region of E13.5 Wt eyes illustrated that Fibrillin-2 was localised
to extracellular regions in the corneal mesenchyme and in the region of
apposition between the lens and neural retina (arrowheads). In contrast,
Fibrillin-2Mp in Mp/Mp eyes was not observed in these extracellular
locations but instead appeared to be retained within cells throughout
the developing eye, with the anterior neural retina (arrows) and
adjacent RPE displaying the most numbers of positive-cells. Scale bars,
50 mm.
doi:10.1371/journal.pgen.1003998.g004
A Trans-Acting Protein Effect in the Mp Mouse Eye
PLOS Genetics | www.plosgenetics.org 6 December 2013 | Volume 9 | Issue 12 | e1003998
highly penetrant homozygous hind-limb syndactyly but no ocular
phenotype [30,31,32]. Thus Mp is likely a Fibrillin-2 null mutation
in limb development but its ocular phenotype clearly resulted from
a separate mechanism, specific to its genomic inversion.
It cannot be ruled out that the extraneous amino acids added by
the out-of-frame fusion to Isoc1 conferred a gain-of-function to this
chimeric protein, preventing its secretion. Although no pro-protein
cleavage by furin has previously been shown directly for Fibrillin-2
at the C-terminal domain, the inclusion data presented here,
together with the high degree of conservation of furin-cleavage
motifs among all Fibrillins [53], strongly suggests that this
processing is common to all Fibrillins but is lost in Fibrillin-2Mp.
It seems likely then that the failure of proprotein processing is the
cause of the intracellular accumulations, and it is the failure of
secretion of Fibrillin-2Mp that is the cause of the UPR.
In addition to the primary secretion failure, ER-stress is likely to
reduce the protein synthesis and/or secretory capacity of affected
cells [54]. We observed a significant reduction in several secreted
proteins from Mp cultured primary cells. The cells in the
developing Mp eye that contain the highest number of Fibrillin-
Figure 5. Fibrillin-2Mp inclusions resulted in ER-stress and cell death in the developing Mp eye. (A) TEM micrograph of Mp/Mp ocular
scleral cells revealed multiple intracellular inclusions located within the enlarged rough endoplasmic reticulum (rER) membrane (arrows). Scale bar,
2 mm. (B) Enlarged micrograph illustrating the structural periodicity of the inclusions with regular banding, possibly representing heterotypic fibrils.
Arrowheads indicate rER membrane. Scale bar, 500 nm. (C) Immuno-gold labelling of the inclusions in Mp/Mp scleral cells with polyclonal anti-
Fibrillin-2 antibody pAb868 and beads conjugated to secondary antibody revealed the inclusions to be composed of Fibrillin-2. (D) Fibrillin-2
immunofluorescence in Mp MEF cultures illustrated the perinuclear localisation and bundle-like organisation of the mutant protein aggregates. Scale
bar, 10 mm. (E) Co-immunofluorescence with anti-ER marker PDI (red) confirmed the Fibrillin-2Mp (green) inclusions colocalised within the ER (yellow
stain; arrow). (F) Staining with the golgi-specific marker GM130 (green staining; arrowhead) showed that Fibrillin-2Mp (red staining, arrows) was not
localised within the Golgi. (G) Non-overlapping staining of Fibrillin-2 (green) and phalloidin (red) indicated that the inclusions were not located in the
cytoplasm. Scale bars in E–G, 100 mm. (H) The ratio of Xbp-1s to Xbp-1u was significantly increased in Mp/Mp compared to Wt in RNA samples
collected from MEFs and from Mp/Mp eyes at E13.5 and E16.5. (I) Section In Situ for ER-stress marker Hspa5mRNA revealed no staining in Wt retinas at
E16.5, (J) however there was clear signal in the non-pigmented ciliary epithelium (arrows) in Mp/Mp. Scale bars, 50 mm. (K) (J) Activated-Caspase-3
stained cells from E13.5 and E16.5 Wt and Mp/Mp retinas were quantified and revealed significant increase in mutant eyes. Error bars are s.d. for H & K
(**P,0.005; *** P,0.001).
doi:10.1371/journal.pgen.1003998.g005
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2Mp inclusions and display a UPR are those at the anterior rim of
the optic cup in the non-pigmented ciliary epithelium. These cells
produce various secreted factors including collagen proteins
required for the accumulation and maintenance of ocular vitreous
[55,56]. In this context it is interesting that the quantitative MS
analysis of the Mp versus Wt MEFs identified several collagen
molecules among the most altered of the secreted proteins. The
reduction of posterior vitreous chamber is an early and prominent
feature of the developmental pathology in the Mp eye. While this
feature could be due to failure of collagen secretion, is it also
plausibly the consequence of a failure in morphogenesis of the
ciliary apparatus itself. Cells in the Fbn2-expressing region of the
embryonic eye also secrete Wnt2b, which is of interest in the
context of the reduction to BAT-gal reporter activity that we
observed in Mp in this region. Disruption of Wnt2b production
results in pan-ocular phenotypes overlapping with those observed
in Mp, including retinal rosettes, lens abnormalities, iris hypoplasia
and the absence of vitreous [27,57]. Wnt2b from the anterior
retina has also been shown to confer layer-organising properties to
the central retina [58]. In Mp, a reduction of Wnt2b from the
ciliary body may be predicted as a result of UPR-mediated
apoptosis (i.e. fewer cells to produce), but may also result from
reduction to the normal secretion of Wnt2b through the ER of
Fbn2 expressing cells, thus reducing the amount of bioactive
paracrine signal available to the developing eye.
One question that arises from this study is why are developing
eyes the only tissues that are sensitive to Fibrillin-2Mp ER-stress,
and not other expressing cells? If we trust the phenotype as an
assay both in the Fbn2 null and Mp animals, this would suggest
that Fibrillin-2 has few non- redundant roles (digit development)
and perhaps in Mp only the developing retinal cells that normally
secrete Fbn2 are co-expressing gene products that are also critical
Figure 6. Fbn2Mp inclusions affect the secretion of extracellular proteins. (A) Conditioned media samples from primary MEF cultures
collected from independent embryos (n= 5 cell lines for each genotype) revealed reductions in secretion of five separate Collagen-family proteins,
Periostin and Follistatin-like 1 by quantitative proteomics using comparative peptide TIC analysis. As a control, the detected levels of BSA
supplemented into the culture media were equivalent (Plots: mean TIC values of proteins secreted from Mp/Mp and Wt cells; error bars, s.d. *P,0.05;
**P,0.01). (B) Top: Immunoblot of total MEF cell lysates with anti-Col6a1 antibody revealed increased intracellular protein in Mp/Mp versus Wt. Below:
Coomassie stained SDS-PAGE gel of conditioned media showed no observable total protein differences between samples. (C) Quantitative RT-PCR
analysis of RNA from MEF samples revealed no significant reduction in mRNA levels of these genes between the two genotypes, indicating that
transcription was not the primary cause of reduced secretion. RNA was extracted from the same cultures as the conditioned media was collected.
Graph represents the mean cT values for Wt and Mp/Mp, divided by the respective mean cT values for Actin mRNA (All PCR reactions were carried out
in triplicate, n= 5 per genotype, error bars, s.d. No differences between means reached significance, Students t-test).
doi:10.1371/journal.pgen.1003998.g006
A Trans-Acting Protein Effect in the Mp Mouse Eye
PLOS Genetics | www.plosgenetics.org 8 December 2013 | Volume 9 | Issue 12 | e1003998
for development. Skin tissue appeared surprisingly lax compared
to Wt (data not shown), and animals were runted. These data
suggest there may also be pathogenic consequences to other
tissues, but that these do not manifest as profoundly as in the
developing eyes, indicating either elevated sensitivity to ER-stress,
or intolerance to reductions of co-secreted proteins in the
developing eye.
It is possible that there are other mechanisms mediating the
protein secretion abnormalities observed inMp in addition to the ER
stress. One such mechanism could relate to the capacity for the ER-
localised Fibrillin-2Mp to bind other proteins. Mutations in COMP
cause human pseudoachondroplasia (PSACH; MIM#177170) and
multiple epiphyseal dysplasia (EDM1; MIM#132400), diseases of
short stature and osteoarthiritis, both of which are associated with
retention of mutant COMP within the rER. The mutations cause a
variety of plausibly pathological effects including: a decrease in
cellular viability, failure of COMP to be secreted into the
extracellular matrix, and a trans-acting effect on co-expressed
proteins [59,60,61]. Mutant COMP accumulates within the
enlarged rER of in vivo cartilage and associates with co-expressed
type IX collagen, with the secretion and extracellular localisation of
these factors correspondingly affected. However, recent analyses of
PSACH mouse models have shown that these effects are not
mediated via UPR but rather through a novel form of chondrocyte
stress [62]. The best-known endogenous Fibrillin-2 binding partners
are the family of latent TGFbeta binding proteins (LTBPs). In this
regard, the observed reduction in secretion of the modulator of BMP
signalling factor, Follistatin-like 1, may be interesting, although there
is currently no direct evidence that this protein binds to either LTBPs
or Fibrillin-2. Interestingly Fibrillin-1 is also a binding partner of
Fibrillin-2 and is similarly processed through the ER, but we were
not able to find any evidence of Fibrillin-1 colocalisation to the Mp
inclusions (see Figure S4). However, we did observe increased
intracellular retention of Col6a1, suggesting that intracellular
association of Collagens to Fibrillin-2Mp may occur. Future work
will be required to determine whether collagens, or Wnt2b, directly
associate with Fibrillin-2Mp inclusions in the developing eye.
We have shown here that the ocular phenotypes inMp are caused
by a truncating mutation in Fbn2. Perturbation of normal ER
function, via mutations similar to Mp in proteins that functionally
pass through the ER, may lead to abnormal phenotypes that cannot
be predicted from knowledge of the primary mutant allele. The
terms antimorphic, and the more commonly used dominant-
negative, are used to describe a worse than heterozygous effect on
the function of the protein encoded by the mutated gene or on the
cognate functional pathway. Here we propose that the Fbn2Mp
mutation is disrupting one or more developmental functions in
which the gene product itself plays no direct part. The compromised
gene products are simply expressed in the same cell and share a
secretory pathway. We suggest the term synodiporic (fellow traveller)
effect for this phenomenon. Thus, the Mp mouse provides clues
towards a genetic mechanism of activating disease mutation, which
may be phenotypically more severe than those predicted simply by
loss of protein function, or may elicit an entirely novel phenotype
due to ER perturbation or any other mechanism affecting the
production or availability of secondary co-expressed proteins. This
has wide-ranging consequences for disease-gene mapping, and for
disease management and therapy in human conditions.
Materials and Methods
Ethics statement
TheMpmouse was re-derived from frozen sperm obtained from
the Jackson Lab (http://www.jax.org/mmdb/results/Sp_Mp.
htmlx). All work was carried out under UK Home Office Project
License 60/3785 (IJ Jackson, MRC Human Genetics Unit).
Rederivation and phenotyping of Mp
Heterozygote (Mp/+) sperm was used to perform intra-
cytoplasmic sperm injection using oocytes from a donor female
F1 (CBA x C57BL/6J). Phenotypically affected offspring were
crossed to C57BL/6J to facilitate genetic mapping and to CD1 for
phenotype and penetrance analysis. The Mp mutation phenotype
has been described [29]. Heterozygote animals were identified by
small eyes with/or without reduced pinnae size. Apparent
anophthalmia (demonstrated by failure to open eyelids) in
combination with distal limb syndactyly was used to identify
homozygote animals. Records of each phenotype were accumu-
lated for penetrance analysis in crosses to both C57BL/6J and
CD1 strains.
Skeletal analysis
Adult animals were culled with lethal intravenous doses of
Euthatal (Merial Animal Health Ltd. Essex, UK), treated in 95%
ethanol for 24 hours; then 72 hours in 100% acetone; a minimum
of 3 days in stain solution (1 part 0.3% alcian blue in 70% ethanol;
1 part 0.1% alazarin red in 95% ethanol; and 1 part acetic acid, in
17 parts 70% ethanol); 3 days in 1% potassium hydroxide (KOH);
3 days in 1% KOH/30% glycerol; and 24 hours in each 1%
KOH/50% glycerol and 1% KOH/70% glycerol and finally
stored in 100% glycerol.
Mouse eye processing for histology and
immunofluorescence
Embryos and eyes were dissected and rinsed in cold phosphate
buffered saline (PBS) and then fixed in 4% PFA overnight at 4uC;
rinsed again in PBS and dehydrated in serial dilutions of ethanol
and paraffin embedded. All adult eye sections were cut using a
standard microtome at 12 mm and oriented in the sagittal plane;
embryonic sections were cut at 6 mm and oriented in the coronal
plane. Haemotoxylin and Eosin staining was performed according
to standard methods.
qRT-PCR and PCR
Details of all primers and sequences used in this study are in
Table S1. DNA was extracted according to established protocols.
RNA was isolated from tissues or from cultured mouse embryonic
fibroblast (MEF) cells using TRIzol Reagent (Invitrogen) accord-
ing to the manufacturers instructions. For cDNA, 1st Strand cDNA
Synthesis Kit for RT-PCR (Roche), or Superscript III (Invitrogen)
were used according to the manufacturers instructions. All PCR
reactions were carried out with primers at 0.2 mM. Cycle
conditions: 95uC63 min; followed by 30 cycles of 95uC630 s;
58uC645 s; 72uC645 s; followed by 10 min at 72uC. Quantitative
RT-PCR was performed as above using Brilliant II SYBR Green
QPCR Master Mix (Agilent) and an ABI HT7900.
Genome-wide mapping of Mp
Microsatellite markers were used for PCR-based mapping using
genomic DNA samples from heterozygous (n=38) offspring from
the 3rd generation of outcrosses to C57BL/6J (for Wt, n=30). In
total 736 markers were selected that were informative between
C3H and C57BL/6J alleles. A list of the markers used and peak
sizes for each allele are available in Table S1. Equimolar samples
were pooled together as either wild type or heterozygote DNA.
Amplicons were analysed on the ABI PRISM 310 Genetic
Analyzer. Peak heights for each allele were recorded and the ratios
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of C57BL/6J:C3H were calculated. For the chromosome 18 locus,
non-fluorescently labeled microsatellite PCR products were
resolved on 4% agarose gels. Oligonucleotides for fine mapping
chromosome 18 are listed in Table S1.
39-End cDNA amplification
Rapid Amplification of cDNA Ends (RACE) was used for the
identification of the 39-end of the Fbn2 transcript using an adaptor
oligonucleotide primer (59-GACTCGAGTCGACATCGATT-
TTTTTTTTTTTTTTT-39) as the only primer in separate
reverse transcription reactions with RNA extracted from pheno-
typically mutant and Wt animals as described above, using 1st
Strand cDNA Synthesis Kit for RT-PCR (Roche) with standard
conditions. The single-stranded cDNA species (cDNA) were then
used in gene-specific PCR reactions with an adaptor-only primer
(59-GACTCGAGTCGACATCG-39) and the Fbn2-specific primer
(59-GTCTCAGCCTTCCCTCTGTG-39). Products from these
separate reactions were then gel electrophoresed and candidate
bands were excised and TA-cloned into the pGEM-Easy vector
system (Promega), according to the manufacturers instructions.
Sequence analysis was performed using T7 and SP6 vector-specific
primers and Sequencher Version 4.8 (Gene Codes Corp. MI,
USA) and then used as query sequences in BLAT search
alignments against the mouse genome (http://genome.ucsc.edu/
cgi-bin/hgBlat). A PCR-based genotyping assay was devised based
on the genomic rearrangement identified at the Mp locus.
Transmission-Electron Microscopy (TEM)
Tissues were collected from freshly culled neonates (P2 and P8)
and placed into sterile serum-free DMEM (Gibco). For ultrastruc-
tural observation, the tissue was fixed for 1–3 hours in 1.5%
Glutaraldehyde/1.5% Paraformaldehyde with 0.05% tannic acid
in DMEM, rinsed in DMEM then immersed in 1% OsO4 in
DMEM for one hour. Tissues were dehydrated in a graded series
of ethanol to 100%, washed in propylene oxide, then infiltrated
and embedded in Spurr’s epoxy. 60–90 nm ultrathin sections were
contrasted with saturated uranyl acetate in 50% ethanol for
15 minutes followed by lead citrate for 3 minutes. For immuno-
cytochemistry, fresh tissue was fixed in 0.1% glutaraldehyde/4%
paraformaldehyde for 30 minutes on ice, rinsed in DMEM then
0.15 M TRIS-HCl (pH 7.4) overnight. Tissues were then exposed
to a graded series of ethanol dilutions to 90% at progressively
lower temperature to 220uC, infiltrated in LR White embedding
media at 220uC, then polymerized at 60uC in a nitrogen
atmosphere. Ultrathin sections mounted on formvar coated
162 mm nickel slot grids were immunolabeled using antibody
pAb0868 specific to Fbn2, pAb9543 specific to Fbn1 and also
control antibodies of irrelevant specificity followed by a combina-
tion of 25 and 210 nm secondary gold conjugates as previously
described [42]. Sections were examined on either a Philips
EM410LS TEM or an FEI G20 TEM operated at 120 kV.
Primary MEF cultures
Genotyped embryos were collected at E13.5 and the limbs and
skin from each embryo were then finely chopped and cultured in
DMEM (Gibco) with 20% foetal calf serum and 1% penicillin/
streptomycin at 37uC; 5% CO2; 3% O2. The Wnt-FLAG
containing plasmid was a kind gift from Dr Angela Lee and
modified from a PCMxGFP2FLAG vector. Transfection of RPE1
cells with Wnt-FLAG were performed using Lipofectamine-LTX
(Invitrogen), with pcDNA3.1 containing enhanced-GFP to control
for transfection efficiency. Tunicamycin (Sigma) was used at a
concentration of 0.5 mg/ml and carried in DMSO. Non-Tn
treated cells were exposed to carrier alone.
Xbp1 splicing assay
Alternatively spliced Xbp1transcripts were differentially identi-
fied using RT-PCR and the ABI PRISM 310 Genetic Analyzer,
using a FAM-labeled forward, and an unlabelled reverse primers
specific for the spliced region of Xbp1 (Table S1). RNA samples
were collected from embryonic eyes and MEF cultures and cDNA
was synthesized. The unspliced (Xbp1u) transcript was 289 bp and
the spliced transcript (Xbp1s) was 263 bp. The assay was verified
using tunicamycin to induce ER-stress in cultured MEFs (data not
shown). Peak heights for each amplicon were measured using the
ABI PRISM 310 Genetic Analyzer, and means were calculated
and displayed graphically.
Immunohistochemistry
All antibodies used in this study are listed in Table S2. For
immunofluorescence, primary MEFs were cultured on glass
coverslips as described above for 72 hours and media was replaced
with serum-free media for 16 hours. Coverslips were fixed (i) for
PDI and GM130 staining- with 3.7% formaldehyde on ice for
10 minutes, or (ii) for Fbn2 with acetone at220uC for 15 minutes,
rinsed once in PBS and then permeabilised in PBS+0.5% Triton-
X-100 (Sigma) for 10 minutes, blocked in PBS+10% serum for
1 hour, and incubated with primary antibodies overnight at 4uC.
Coverslips were washed 365 minutes in PBS, and incubated in
Alexa Fluor F(ab9) fragment (Invitrogen) secondary antibodies
diluted 1:1000 in blocking buffer for 1 hour and mounted with
ProLong Gold Antifade reagent (Invitrogen). For immunohisto-
chemistry, paraffin sections were de-waxed and antigen retrieval
was performed by boiling slides in 0.1 M Citrate buffer (pH 6.0)
for 5 minutes. Paraffin or cryosection samples were then rinsed in
PBS and blocked for 1 hr in buffer containing 10% serum (heat
inactivated at 60uC for 1 hr); 1% BSA; 0.1% Tween-20; 0.05%
Triton-X-100, all in PBS. Primary and secondary antibodies were
applied as before. Colorimetric immunohistochemistry was
performed using Vectastain ABC kits (Vector Laboratories) with
alkaline phosphatase detection and BM Purple (Roche). Imaging
was performed using a Zeiss Axioplan II fluorescence microscope
with Plan-neofluar objectives. Images were captured using a
Coolsnap HQ CCD camera (Photometrics Ltd, Tucson, AZ).
Image analysis was performed using IPLab Spectrum Software
(Scanalytics Corp, Fairfax, VA).
RNA In Situ analysis and riboprobe synthesis
Riboprobe synthesis primers are listed in Table S1. Purified
PCR products were incubated for 37uC for 2 h in a 20 ml reaction
containing: 2 ml transcription buffer; 1 ml RNase inhibitor; 2 ml
DIG RNA labelling mix and T7 RNA polymerase (all Roche); in
ultra-pure H2O. Riboprobes were then DNAseI treated and
Sodium-acetate/Ethanol precipitated. Whole-mount in situ hy-
bridization to mouse embryos was carried out as previously
described [63]. For section in situ, tissue sections were prepared as
described for immunohistochemistry, and processed as described
in J. Rainger’s doctoral thesis (available on request). X-gal staining
was performed on dissected embryos for beta-galactosidase activity
as described in [18].
Secretion assays
For secretion assays, 16105 cells were seeded into 6-well plates
and cultured under normal conditions for 3 days. Five indepen-
dent cell lines were used per genotype. Media was removed and
replaced with 1 ml DMEM (Gibco) with reduced serum and
cultured for a further 72 hours. The conditioned media was
collected and 500 ml was concentrated 10 fold using an Amicon
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Ultra 30 K (Millipore) centrifugal filter according to the manu-
facturers instructions. Concentrated conditioned media samples
were then both (i) run on 10% NuPAGE Novex Bis-Tris Mini Gel
SDS polyacrylamide gel (Invitrogen) and stained with 0.05%
Coomassie Brilliant Blue (40% methanol, 10% acetic acid), and (ii)
measured for total protein by Bradford assay, to ensure equal
protein content per sample. Their protein composition in these
media were analysed using a label-free shotgun proteomics
method according to a previous report [64] with some modifica-
tions. First, the database search was performed using Proteome
Discover (version 1.2) or Peaks (Peaks Scientific, version 6.0) with
peptide false discovery rate constrained at 1%. Second, parent ion
mass tolerance and fragment ion mass tolerances were set at
5 ppm and 0.6 Da. Third, Sieve software (version 2.0; Thermo
Scientific) and Peaks (Peaks Scientific) were used to compare
protein abundance with a total ion current normalization. Only
more than two peptides per protein detectable was considered and
each protein was expressed as a ratio Mp/Mp:Wt according to
Asara et al [65]. For transcript analyses, cells were dissociated and
counted using a haemocytometer and total RNA extractions were
performed with Trizol reagent (Invitrogen) and cDNA prepared.
qRT-PCR was performed on ABI HT7900 using 0.5 M sequence-
specific primers for Col6a1; Col3a1; Col1a2; Col12a1; Fstl1; Postn;
and Actn1 with Brilliant II SYBR Green QPCR mix (Agilent) and
0.4 ml of cDNA template per 20 ml reaction. Each sample was run
in triplicate per qRT-PCR reaction and the data presented
represents the mean of 5 independent samples per genotype and
three separate qRT-PCR technical repeat. For relative expression,
all CT values were normalized to CT-ß-Actin.
Immunoblotting
Protein samples were run on NuPage SDS polyacrylamide gels
and transferred to a PVDF membrane, blocked for 1 hour in 5%
non-fat dry milk diluted in PBS and incubated overnight in
primary antibodies diluted in block. Membranes were washed
extensively in PBS and incubated in the relevant secondary IgG-
HRP antibody diluted in block for 1 hour at room temperature.
Membranes were then washed again and immuno-complexes were
visualized with Amersham ECL Western Blotting Detection
Reagent (GE Healthcare Life Sciences).
Supporting Information
Figure S1 (A) Average weights (in grams) recorded between
postnatal days 4 and P21 showed reduced weight of Mp/Mp from
P4 compared to Wt and Mp/+. In addition, both mutant types
failed to gain weight compared to Wt. Error bars, s.d. (B)
Phenotype data from out-crosses (top) and intercrosses (bottom) to
C57BL6/J and CD1 genetic backgrounds revealed that the Mp
phenotype was fully penetrant on both strains.
(TIF)
Figure S2 (A) Haemotoxylin and eosin staining of P21 retinal
tissue revealed retinal rosetting affecting the inner nuclear layer
cells (arrows). Scale bar, 100 mm. (B) Immunohistochemical
marker analysis revealed gross disruption to Mp retinas at P21.
Staining for Rhodopsin was localised to punctate regions of the
mutant retina (arrows), consistent with rosette foci, and was not
identified in the outer segment of the retina, in contrast to the Wt
retina where Rhodopsin signal was localised to the outer segment
(arrows) and the outer nuclear layer (arrowheads). DAPI
counterstaining illustrated the disruption to the normal lamination
of the Mp retina compared to Wt. Vsx2 antibody staining
displayed a reduced number of cells in the Mp inner nuclear layer,
and staining for Calbindin was reduced in the Mp outer plexiform
layer (arrows), indicating a disruption to the projections emanating
from horizontal cells of this region of the retina. GFAP (glial
fibrillary acidic protein) staining, a marker for Muller glial cells
and retinal astrocytes but also retinal stress responses, was
markedly increased in mutant eyes. Brn3a, expressed in retinal
ganglion cells (arrows) displayed ectopic staining in multiple
regions of the Mp/Mp retina (arrowheads) and revealed a
reduction to the typical ganglion layer compared to Wt.
Abbreviations: gcl, ganglion cell layer; inl, inner nuclear layer;
ipl, inner plexiform layer; is, inner segment; onl, outer nuclear
layer; opl, outer plexiform layer; os, outer segment; rpe, retinal
pigmented epithelium. Scale bar = 100 mm. (C) Mean retinal
widths at E15.5 measured in voxel units using OPT data from
whole embryonic heads. Error bars, s.d. Wt n=5; Mp/Mp n=8.
***P,0.001 (Student’s t-test). (D) Quantitative ß-galactosidase
staining of Wt:BAT-Gal and MpMp:BAT-Gal eyes at E14.5 was
performed by the segmentation of the eye into 6 regions of interest
(ROI) and staining intensity was measured for each ROI using
Photoshop software (Adobe) and normalised to the ventral ROI
for each eye analysed. n = 8 eyes per genotype. The mean of each
region was used to graph the difference between genotypes for
each comparative ROI. Error bars, 95% confidence intervals. All
differences were significant with P,0.001 (Student’s t-test).
(TIF)
Figure S3 (A) Comparative RACE analysis of the 39-terminal
region of Fbn2 identified a Wt-Fbn2 amplicon of the predicted size
present in the Wt transcript (arrow) but absent in Mp/Mp; and a
smaller amplicon that was present in Mp/Mp (arrowhead) but
absent from Wt. (B) RT-PCR using primers specific for the 39-ends
of each Fbn2 and Isoc1 failed to amplify products from homozygote
cDNA. However, using different combinations of these primers
(e.g. Fbn2 39-fwd with the Isoc1 reverse primer; or the Isoc1-39-fwd
primer with a Fbn2 reverse) confirmed the reciprocal fusion
between Fbn2 and Isoc1 mRNAs prepared from MEF cultures.
Slc27a6 expression was unaffected. Bottom panel is control RT-
PCR for ß-Actin. (C) Isoc1 and Slc27a6 expression by quantitative
RT-PCR using cDNA prepared from E13.5 eyes. Isoc1 mRNA
was ,50% reduced in Mp/Mp compared to Wt, whereas Slc27a6
mRNA levels showed no difference. (D) H&E-stained eye sections
showed that Fbn2tm1rmz/tm1rmz eyes from the 6th back-cross to
C57BL/6J, displayed no structural abnormalities at P0, whereas
stage-matched Mp/Mp eyes displayed clearly identifiable overall
size reduction, absent vitreous, thinned non-pigmented ciliary
margin (arrowheads), and some retinal-layer disruption (arrows).
(E) Similarly, adult stage P21 Fbn2tm1rmz/tm1rmz retinas on a 129/Sv
background displayed no structural abnormalities (compare to Wt
& Mp P21 eye sections in Figure 2).
(TIF)
Figure S4 (A) Reciprocal in situ hybridisation of E11.5 embryos
for Fbn2, Isoc1 and Slc27a6 showed ocular (arrowhead), limb (red
arrowhead) and somite (arrows) expression of Fbn2 in Wt and Mp/
Mp embryos. Ocular expression from digital coronal sections of
Isoc1 and Fbn2 is also presented (red arrows). No Isoc1 or Slc27a6
expression was detected in either genotype. Note the 39-riboprobes
were used reciprocally, with the Fbn2 and Isoc1 probes acting as
useful positive controls. n=3 embryos per genotype for each RNA
probe. (B) Further reciprocal in situ hybridisation of E14.5 hind
limbs for Fbn2 and Isoc1 showed that spatial and temporal
expression of Fbn2 and Fbn2Mp was unaffected by theMpmutation.
(C) Immunostaining of primary MEF cultures established from
wild type and Mp/Mp embryos with pAb868 revealed differences
in Fbn2 localisation. Mp Fbn2 was intracellular, whereas Wt
appeared extracellular. (D) Similarly, Wt hind-limb articular
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cartilage revealed typical extracellular microfibrillar localisation of
Fibrillin-2. Arrowheads in inset indicate the Fibrillin-2 positive
microfibrils in a higher magnification image. In contrast, Fibrillin-
2Mp in equivalent mutant tissue was identified in discrete foci
(arrows in inset) adjacent to cell nuclei (DAPI, blue stain) and
appeared intracellular. (E) Top: Analysis of neonatal skin sections
with pAb868 for Fibrillin-2 localisation revealed differential
staining between genotypes, with extracellular protein organised
into microfibrils in Wt dermis but not in Mp/Mp, where the
mutant protein was observed in discrete foci and not observed
extracellularly. Bottom: Equivalent staining for Fibrillin-1 localisa-
tion displayed comparable extracellular localisation in Wt and Mp,
and no intracellular localisation was observed. Similar results were
observed with perichondrium and nerve tissue (data not shown).
Scale bars = 50 mm. Abbreviations: hf, hair follicle.
(TIF)
Figure S5 (A) Immunostaining for PDI protein (dark, colouro-
metric stain) was not strongly observed in Wt eyes, but in the
developing Mp/Mp eye (B) PDI was spatially consistent with
Fbn2Mp inclusions at the distal retina (arrows) and adjacent rpe. (C)
Fbn2Mp (green) and PDI colocalisation was observed at the anterior
neural retina and RPE in Mp/Mp cells using serial immunohisto-
chemistry. (D–G) Anti-activated caspase-3 antibody staining in Wt
anterior and central retina revealed no apoptotic cells. In contrast,
staining of retinal sections at anterior or central regions revealed an
increase in signal foci (arrowheads) inMp/Mp eyes, but that positive
cells were distributed throughout the retina and were not specific to
the anterior region of the developing Mp eye.
(TIF)
Figure S6 Conditioned media and cell lysates from Wt human
RPE1 cultures transiently transfected with Wnt-FLAG and
chemically induced for ER-stress with tunicamycin treatment
(Tn) were collected and immunoblotting was performed. In the
conditioned media from the Tn-treated cultures, both signal
intensity and band migration of Wnt-FLAG were reduced
compared to the untreated cultures, consistent with the inhibition
to both glycosylation and secretion. In the cell lysates however,
only the size of the migrated protein was different between
samples. Immunoblotting of cell lysates with anti-Hspa5 antibody
confirmed the induction of ER-stress in the Tn treated samples.
(TIF)
Table S1 Oligonucleotide primers used in this study.
(DOCX)
Table S2 Primary antibodies used in this study.
(DOCX)
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